Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ECCLIPSE: IV Lysine Acetylsalicylate vs Oral Aspirin with Prasugrel
NCT02243137Phase 1Completed
- Start
- May 2013
- Primary completion
- Jun 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of lysine acetylsalicylate in acute coronary syndrome (ACS). Primary endpoint: Inhibition of platelet aggregation. Started May 2013; status: completed.
02
Drugs
lysine acetylsalicylate
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT02243137.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02243137.